Showing: 1 - 6 of 6 RESULTS

Cy-Fair ISD school board approves additional desk shields for second half of semester

With more students returning for the second half of the fall semester, the Cy-Fair ISD board of trustees approved the purchase of additional desk and tabletop protective dividers for protection during the COVID-19 pandemic.

After Trustee Tom Jackson asked about the desk shields’ effectiveness, Chief of Staff Teresa Hull said the shields have been approved by Memorial Hermann doctors collaborating with the school district and advising the district on precautionary COVID-19 measures.


“When we started looking at the number of students that we anticipated would be returning to campus, especially the second marking period, we reached out to Memorial Hermann and asked that very question,” Hull said. “They felt very strongly that that absolutely was a layer of protection; when you couple it with the mask, it definitely is helping us minimize the number students that may be identified as a close contact (during contact tracing).”

Previously, Chief Financial Officer Karen Smith said the district is working on recovering funds used on COVID-19 precautions and online learning.

“Because we didn’t have face to face (instruction) in the building there are costs we simply did not incur,” Smith said. “But if you recall we have instructional packets that we delivered. We purchased PPE when we were planning for this before COVID actually hit so bad that the schools were closed.”

Cy-Fair ISD has lost $2.2 million in revenue from food services, $16.1 million is expected to be spent from the general fund for the 2020-2021 school year, $500,000 was spent on personal protective equipment and $5.2 million for social distancing measures and more according to the presentation from Oct. 8.

[email protected]

Source Article

Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ — Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz, MD, PhD and Elizabeta Nemeth, PhD to its scientific advisory board, adding valuable expertise in hepcidin biology.

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic diseases. (PRNewsfoto/Disc Medicine)

“We are thrilled to welcome  Dr. Ganz and Dr. Nemeth to our Scientific Advisory Board, particularly at such an exciting time in a field that they helped pioneer,” said John Quisel, JD, PhD, Chief Executive Officer at Disc Medicine. “Together they were instrumental in characterizing the fundamental role of hepcidin in iron homeostasis, and I’m delighted to be working with them as we advance our hepcidin-targeted programs into the clinic.”

Dr. Ganz is a Distinguished Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, where he studies the role of small peptide regulators in human physiology and disease and is credited for the discovery of the iron-regulatory hormone hepcidin. Dr. Ganz received his PhD in Applied Physics from Caltech and his MD from UCLA, joining UCLA as a faculty member in 1983 after having completed training in Internal Medicine and Pulmonary Medicine. In 2005 he received the Marcel Simon Prize of the International Bioiron Society for the discovery of hepcidin and in 2014 was honored by the E. Donnall Thomas Award from the American Society of Hematology for his research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism.

“It has been immensely gratifying to see the hepcidin story unfold as our understanding of hepcidin’s role across different diseases has grown,” said Tomas Ganz, MD PhD. “Disc has taken a compelling approach to targeting hepcidin with two programs guided by human genetic findings. I’m delighted to be a part of this vision, particularly as they look to enter the clinic with their first program next year.”

Dr. Nemeth is a Professor of Medicine at the David Geffen School of Medicine at UCLA, and Director of the UCLA Center for Iron Disorders. Dr. Nemeth received her PhD in Cell, Molecular and Neurosciences at the University of Hawaii and completed a postdoctoral fellowship studying the pathobiology of hepcidin at UCLA. During her tenure she has made major contributions to the understanding of iron homeostasis and its dysregulation in disease, such as characterizing the regulation of hepcidin production by inflammation and iron and elucidating the mechanism of action of hepcidin in regulating dietary iron absorption and release from stores. Dr. Nemeth also described the role of hepcidin in various iron disorders including hereditary hemochromatosis, iron-loading anemias and iron-restricted anemias. Dr. Nemeth was a standing member of the Molecular and Cellular Hematology Study Section of the National Institutes of Health, is President-Elect of the International BioIron Society, and an associate editor of the American Journal of Hematology. Dr. Ganz and Nemeth co-founded three biotechnology companies focused on hepcidin-targeted

Pamela M. Sutton-Wallace Appointed to J2 Global Board of Directors

J2 Global, Inc. (NASDAQ: JCOM), a leading Internet information and services company, today announced the appointment to its board of directors of Pamela M. Sutton-Wallace, MPH, an experienced healthcare executive who has worked in several leading academic medical centers.

“We are delighted to have Pam join our Board of Directors,” said J2 Global Board Chairman Richard Ressler. “She is a nationally recognized leader in healthcare who will bring deep operating and strategic expertise to our Board.”

Pam brings more than 25 years of healthcare industry experience and currently serves as Senior Vice President and Regional Chief Operating Officer of New York Presbyterian. Previously, Pam was Chief Executive Officer at the University of Virginia Medical Center. Prior to that, Pam served as Senior Vice President of Hospital Operations at Duke University Hospital, where she also held leadership positions across the Duke University Health System. Pam earned a Master’s of Public Health from Yale University School of Public Health and a Bachelor of Arts in Political Science and African-American Studies from Washington University.

“Given the importance of healthcare within J2 Global’s portfolio, Pam’s wealth of experience at some of the world’s most renowned health systems will make her a valuable addition to our company,” said J2 Global CEO Vivek Shah.

“I am thrilled to join J2 Global’s Board of Directors,” said Sutton-Wallace. “With the healthcare industry continuing to adopt and integrate information technology, this is an ideal time to be part of an organization providing digital solutions to patients and healthcare professionals.”

About J2 Global®

J2 Global, Inc. (NASDAQ: JCOM) is a leading Internet information and services company consisting of a portfolio of brands including IGN, Mashable, Humble Bundle, Speedtest, PCMag, Offers.com, Spiceworks, Everyday Health, BabyCenter and What To Expect in its Digital Media segment and eFax, eVoice, iContact, Campaigner, Vipre, IPVanish and KeepItSafe in its Cloud Services segment. J2 Global reaches over 230 million people per month across its brands. As of December 31, 2019, J2 Global had achieved 24 consecutive fiscal years of revenue growth. For more information, visit: www.j2global.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201012005125/en/

Contacts

Rebecca Wright
(212) 503-5247
J2 Global, Inc.
[email protected]

Source Article

Washington Post board urges more transparency on Trump health: ‘No more spin doctors’



a group of people standing in front of a building: Washington Post board urges more transparency on Trump health: 'No more spin doctors'


© Getty Images
Washington Post board urges more transparency on Trump health: ‘No more spin doctors’

The Washington Post’s editorial board on Friday called for the White House to be more transparent about the state of President Trump’s health, demanding “more than spin doctors.”

“All presidents like to project robust health and are loath to admit weakness, even if caused by events beyond their control.” the board wrote in an opinion piece, citing when President Reagan was shot in 1981.

“But when a president’s health is abnormal, the public has a right to know, especially if the problem has any effect on his fitness to perform his duties. In Mr. Trump’s case, the unanswered questions are glaring,” they continued.

Trump was brought to the Walter Reed Medical Center on Friday, Oct. 2, just hours after announcing that both he and first lady Melania Trump had tested positive for the coronavirus.

The next day, doctors offered a rosy assessment of Trump’s health during a televised briefing. But statements The Associated Press and other outlets later attributed to White House chief of staff Mark Meadows and other sources gave a more alarming account of the president’s health.

The White House later acknowledged that Trump had received oxygen as he was being treated for COVID-19 after White House physician Sean Conley initially sidestepped answering on the topic. Conley maintained the team briefing on Trump’s condition wasn’t “necessarily” trying to “hide” anything from the public.

Conley later disclosed during a briefing with reporters that Trump received supplemental oxygen after his diagnosis.

When asked why he had been reluctant to disclose whether Trump had received oxygen, Conley said he was “trying to reflect the upbeat attitude that the team, the president, that his course of illness has had.”

This week, Conley repeatedly ducked more questions about Trump’s health and the timeline of his infection, even though Trump was deemed well enough to leave the hospital and return to the White House.

The Washington Post board noted that Trump had a packed schedule the week before his coronavirus diagnosis, which included introducing his Supreme Court nominee Amy Coney Barrett in a White House Rose Garden event.

The White House has battled a spate of recent COVID-19 diagnoses among staff, leading Anthony Fauci, the nation’s top infectious disease expert, to describe what he called a “superspreader event” at the White House.

According to a Federal Emergency Management Agency (FEMA) memo obtained by ABC News this week, 34 White House staffers and “other contacts” have been infected with the coronavirus in recent days.

“Leadership matters, and Mr. Trump has been calamitously unable to provide it. In the pandemic, he offered glib reassurances when the nation needed realism,” The Post’s editorial concluded. “On the question of his personal health, a matter of public interest, we need more than spin doctors. We need real doctors providing real information.”

Trump plans to hold an in-person event at the White House on Saturday, two officials confirmed to The Hill, his first

Members resign from Saratoga EDC board

SARATOGA SPRINGS – The controversy over claims the Saratoga Prosperity Partnership’s downloading and sharing of a confidential Saratoga Economic Development Committee Zoom meeting continues with board resignations and an investigation.

On Wednesday afternoon, the Partnership will be briefed on a report by an attorney the group hired to investigate the matter amid SEDC’s accusations that its civil liberties were violated by the distribution of a video of one of its meetings. SEDC is a private nonprofit and its meetings are not open to the public.

The Partnership report follows the departure of four from the SEDC board: Saratoga Hospital President and CEO Angelo Calbone, land-use attorney Matt Jones, Adirondack Trust Executive Vice President Michael O’Connell and Saratoga County Chamber of Commerce President Todd Shimkus.

“It doesn’t have a negative effect,” said SEDC Board Chair John Munter Jr. of the board resignations. “They all left for different reasons. The feeling was that in this fight, there is a lot of varied opinions. They just wanted to step aside in order to let things take their course in a more natural way.”

The departures, as first reported by the Albany Business Review, come during an on-going, years-long squabble between SEDC and the county-funded Partnership. Under a 2019 county plan, the two entities are supposed to be working together. That is the reason, Munter said, SEDC obtained a Zoom license through the Partnership for a discounted rate of $20 a month. At the time, Munter said, it was verbally confirmed that the SEDC meetings would be property of SEDC only.

But SEDC now accuses Partnership President Shelby Schneider, and her executive assistant, Michele Battle, of accessing SEDC’s private Zoom meetings, downloading the recordings and sharing them. SEDC attorney Michael Bilok, in a letter to the Partnership, said that the allegations against Schneider and Battle could rise to a criminal level, including violating the Stored Communication Act and the Defend Trade Secrets Act. In the video, Brobston allegedly insulted some prominent business leaders and elected officials.


“The content of the video is comparable to middle school banter,” Munter said. “There is nothing unlawful or no civil or lawful violations. The video itself is very petty. People were insulted. But SEDC’s civil liberties were violated by obtaining it and our civil liberties were violated when they shared it.”

Munter said this is part of a larger vendetta against SEDC and its president, Dennis Brobston. He explained that six years ago when the county established the Partnership, an effort to overtake SEDC’s economic authority, lead Partnership architect Waterford Supervisor John Lawler said it “wouldn’t be over until Dennis Brobston is out and SEDC is out of business.”

Lawler said on Wednesday that is “a malicious and absolute lie.”

“Why doesn’t (Munter) focus on why his board members resigned,” said Lawler, who himself quit the Partnership board in February 2019 when discussions about merging the two economic entities began.

At that point, the county stripped SEDC of all funding and formed the Partnership, which in the past

EyeGuide Adds Six Sports Medicine, Neuroscience Experts to Scientific Advisory Board

EyeGuide Inc., a health technology and bioinformatics company revolutionizing the way brain health is monitored, has announced the expansion of its scientific advisory board with the additions of Dr. Anne Naclerio, Dr. Dhiren Naidu, Dr. Jon Patricios, Dr. Kathryn Schneider, Dr. Karen Sutton and Dr. Michael Turner. Each of these leading scientific experts brings specialized skills, knowledge and experience to help the EyeGuide team build a world-class advisory board.

“EyeGuide is doing important work to improve ocular-motor assessment of athletes with suspected brain injuries, to advance brain health, and to improve the wellness and performance of athletes of all ages. This is an exciting step forward for EyeGuide as the company now gains further support from an array of respected senior experts across the field of sports medicine and neuroscience,” said Dr. Ruben Echemendia, Chairperson of EyeGuide Scientific Advisory Board, which was established earlier this year. “I am eager to work together with this impressive team of advisers as well as collaborate on providing insight and guidance to EyeGuide so its products may help improve the lives of many people across the U.S. and around the world.”

The new members of EyeGuide’s Scientific Advisory Board include:

  • Dr. Anne Naclerio has spent the past 10 years working as chief of clinical operations for the Regional Health Command Atlantic, deputy surgeon for the U.S. Army in Europe, the command surgeon for the Army National Guard, and the chief of medical readiness and policy for the U.S. Army Surgeon General. Dr. Naclerio served in the Army for over 30 years and has earned numerous decorations including the Bronze Star, Purple Heart and the Legion of Merit. She also established and led the Women’s Health Taskforce to enable the services to better understand and meet the unique needs of female service members.

  • Dr. Dhiren Naidu is a tenured associate professor in the Division of Physical Medicine and Rehabilitation at the University of Alberta. He is also currently the head team physician for the National Hockey League’s Edmonton Oilers, the lead physician for the Canadian Football League’s Edmonton Eskimos, the head physician for the University of Alberta Golden Bears football team and a health physician for their varsity athletic program.

  • Dr. Jon Patricios is an associate professor in the Wits Faculty of Health Sciences and director of Wits Sport and Health (WiSH). He is also the current director of Waterfall Sports Orthopaedic Surgery in Johannesburg; founder and Director of Sports Concussion South Africa; sports concussion consultant to World Rugby; a board member of the international Concussion in Sports Group; and on the Scientific Committee for the International Consensus Conference on Concussion in Sport. He is a fellow of the American College of Sports Medicine, the Faculty of Sports & Exercise Medicine (UK) and the International Sports Medicine Federation. Jon serves on the advisory board of the Sports Health and Safety Institute at the University of Washington, Seattle. Apart from sports concussion, he has an interest in the pediatric and aging athlete, joint disease, tendinopathy, and